Clinical Trial Update: XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema [Phase 3]

View source ↗

Summary

Phase 3 trial of XERECEPT (human corticotropin-releasing factor) in primary glioma patients requiring dexamethasone to treat peritumoral brain edema has been wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Edema
• Brain Tumor
• Glioma

Drugs mentioned

• XERECEPT (human corticotropin-releasing factor)

Snippet

Sponsor: Celtic Pharma Development Services | Conditions: Brain Edema, Brain Tumor | Phase 3 | Status: WITHDRAWN